Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

By Eisenstein Barry I  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1159-1169

Informa Healthcare

Access to resources Recommend Favorite

Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite

Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia

By Rubinstein Ethan   Corey G Ralph   Stryjewski Martin E   Kanafani Zeina A  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2737-2750

Informa Healthcare

Access to resources Recommend Favorite

Tigecycline for the treatment of infections due to resistant Gram-positive organisms

By Squires Ronald A   Postier Russell G  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 155-162

Informa Healthcare

Access to resources Recommend Favorite

Development of DNA polymerase IIIC inhibitors for the treatment of Gram-positive bacterial infections

By Ali Amjad   Taylor Gayle E  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 8, 2005-08 ,pp. : 947-953

Informa Healthcare

Access to resources Recommend Favorite